Company Overview of Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for prostate cancer and other hormonally-driven diseases. Its lead drug candidate, galeterone, is a multi-targeted, oral small molecule being developed for the treatment of patients with metastatic castration-resistant prostate cancer. The company’s ARDA drug discovery program is focused on the identification and evaluation of compounds that are designed to disrupt androgen receptor signaling through enhanced androgen receptor degradation and are targeted to patients with androgen receptor signaling diseases, including prostate cancer. The company was founded in 2004 and is based in ...
255 State Street
Boston, MA 02109
Founded in 2004
Key Executives for Tokai Pharmaceuticals, Inc.
Chief Executive Officer, President and Director
Total Annual Compensation: $608.5K
Chief Financial Officer
Total Annual Compensation: $201.7K
Chief Medical Officer and Head of Research & Development
Total Annual Compensation: $408.8K
Compensation as of Fiscal Year 2014.
Tokai Pharmaceuticals, Inc. Key Developments
Tokai Pharmaceuticals, Inc. Presents at Jefferies Autumn 2015 Global Healthcare Conference, Nov-19-2015 12:40 PM
Nov 5 15
Tokai Pharmaceuticals, Inc. Presents at Jefferies Autumn 2015 Global Healthcare Conference, Nov-19-2015 12:40 PM. Venue: The May Fair Hotel, Stratton Street, London, United Kingdom.
Tokai Pharmaceuticals, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 03:00 PM
Nov 5 15
Tokai Pharmaceuticals, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 03:00 PM. Venue: The New York Palace Hotel, Hubbard Room, New York, New York, United States. Speakers: Jodie Pope Morrison, Chief Executive Officer, President and Director.
Tokai Seeks Acquisition
Oct 9 15
Tokai Pharmaceuticals, Inc. (NasdaqGM:TKAI) intend to use the net proceeds from the sale of securities for general corporate purposes. General corporate purposes may include the research, development and commercialization of products arising out of our product development pipeline, acquisition of companies or businesses, repayment and refinancing of debt, working capital and capital expenditures.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|